Janssen-Ortho Inc. v. Canada (Minister of Health)
Court headnote
Janssen-Ortho Inc. v. Canada (Minister of Health) Court (s) Database Federal Court of Appeal Decisions Date 2004-02-09 Neutral citation 2004 FCA 62 File numbers A-171-03 Decision Content Date: 20040209 Docket: A-171-03 Citation: 2004 FCA 62 CORAM: ROTHSTEIN J.A. EVANS J.A. PELLETIER J.A. BETWEEN: JANSSEN-ORTHO INC. Appellant and THE MINISTER OF HEALTH and THE ATTORNEY GENERAL OF CANADA Respondents Heard at Toronto, Ontario, on February 9, 2004. Judgment delivered from the Bench at Toronto, Ontario, on February 9, 2004. REASONS FOR JUDGMENT OF THE COURT BY: ROTHSTEIN J.A. Date: 20040209 Docket: A-171-03 Citation: 2004 FCA 62 CORAM: ROTHSTEIN J.A. EVANS J.A. PELLETIER J.A. BETWEEN: JANSSEN-ORTHO INC. Appellant and THE MINISTER OF HEALTH and THE ATTORNEY GENERAL OF CANADA Respondents REASONS FOR JUDGMENT OF THE COURT (Delivered from the Bench at Toronto, Ontario, on February 9, 2004) ROTHSTEIN J.A. [1] In spite of counsel's able argument, we have not been convinced that this case is distinguishable from Novartis Pharmaceuticals Canada Inc. v. Canada (Minister of Health) (2003), 28 C.P.R. (4th) 1, 2003 FCA 299. Nor have we been persuaded that the Court in Novartis was manifestly wrong in the sense that it overlooked a relevant statutory provision i.e. section 4 of the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133, as amended by SOR/98-166. [2] Having regard to Novartis and Miller v. Canada (Attorney General) (2002), 220 D.L.R. (4th) 149, 2002 FCA 370, we will …
Read full judgment
Janssen-Ortho Inc. v. Canada (Minister of Health) Court (s) Database Federal Court of Appeal Decisions Date 2004-02-09 Neutral citation 2004 FCA 62 File numbers A-171-03 Decision Content Date: 20040209 Docket: A-171-03 Citation: 2004 FCA 62 CORAM: ROTHSTEIN J.A. EVANS J.A. PELLETIER J.A. BETWEEN: JANSSEN-ORTHO INC. Appellant and THE MINISTER OF HEALTH and THE ATTORNEY GENERAL OF CANADA Respondents Heard at Toronto, Ontario, on February 9, 2004. Judgment delivered from the Bench at Toronto, Ontario, on February 9, 2004. REASONS FOR JUDGMENT OF THE COURT BY: ROTHSTEIN J.A. Date: 20040209 Docket: A-171-03 Citation: 2004 FCA 62 CORAM: ROTHSTEIN J.A. EVANS J.A. PELLETIER J.A. BETWEEN: JANSSEN-ORTHO INC. Appellant and THE MINISTER OF HEALTH and THE ATTORNEY GENERAL OF CANADA Respondents REASONS FOR JUDGMENT OF THE COURT (Delivered from the Bench at Toronto, Ontario, on February 9, 2004) ROTHSTEIN J.A. [1] In spite of counsel's able argument, we have not been convinced that this case is distinguishable from Novartis Pharmaceuticals Canada Inc. v. Canada (Minister of Health) (2003), 28 C.P.R. (4th) 1, 2003 FCA 299. Nor have we been persuaded that the Court in Novartis was manifestly wrong in the sense that it overlooked a relevant statutory provision i.e. section 4 of the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133, as amended by SOR/98-166. [2] Having regard to Novartis and Miller v. Canada (Attorney General) (2002), 220 D.L.R. (4th) 149, 2002 FCA 370, we will dismiss this appeal with costs to the respondents of $2,000 inclusive of disbursements. "Marshall Rothstein" J.A. FEDERAL COURT OF APPEAL Names of Counsel and Solicitors of Record DOCKET: A-171-03 STYLE OF CAUSE: JANSSEN-ORTHO INC. Appellant and THE MINISTER OF HEALTH and THE ATTORNEY GENERAL OF CANADA Respondents DATE OF HEARING: FEBRUARY 9, 2004 PLACE OF HEARING: TORONTO, ONTARIO REASONS FOR JUDGMENT OF THE COURT BY: (ROTHSTEIN, EVANS & PELLETIER JJ.A.) DELIVERED FROM THE BENCH BY: ROTHSTEIN J.A. APPEARANCES BY: Ms. Sheila Block Mr. Andrew Shaughnessy FOR THE APPELLANT Ms. Marie Crowley FOR THE RESPONDENTS SOLICITORS OF RECORD: Torys LLP Toronto, Ontario FOR THE APPELLANT Morris Rosenberg Deputy Attorney General of Canada Toronto, Ontario FOR THE RESPONDENTS
Source: decisions.fca-caf.gc.ca